<DOC>
	<DOCNO>NCT02903251</DOCNO>
	<brief_summary>This study evaluate effect oxytocin nasal spray alcohol withdrawal dependence adult admit detoxification alcohol , follow 4 week outpatient set . Half participant receive oxytocin nasal spray , half placebo nasal spray .</brief_summary>
	<brief_title>Oxytocin Alcohol Withdrawal Dependence</brief_title>
	<detailed_description />
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>1 . At least one prior episode 2 day long duration subject experience withdrawal symptom cause significant incapacitation ( e.g. , inability work normal activity ) OR least one prior inpatient outpatient medical detoxification subject exhibit withdrawal symptom sufficient magnitude sedativehypnotic anticonvulsant medication require least 2 consecutive day cessation reduction use alcohol follow 2 week heavy daily consumption 2. average consumption 830 standard drink per day least 2 week prior enrollment study ; 3. consent participate study ; 4. residency Tr√∏ndelag County discharge 1. chronic treatment sedativehypnotic medication benzodiazepine zhypnotics ; 2. dependence substance alcohol , nicotine caffeine ; 3. inadequately treat , unstable and/or compromise medical psychiatric condition ; 4. low body weight ( BMI &lt; 17 ) history anorexia nervosa bulimia past 2 year ; 5. pregnancy ; parturition breastfeed past 6 month ; 6. inability read well enough complete study questionnaire determine whether prospective subject read consent form without help correctly answer basic question information consent form ; 7. alcohol blood &gt; 15 h since last intake alcohol ; 8. prior inclusion participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Oxytocin</keyword>
	<keyword>Administration , Intranasal</keyword>
	<keyword>Ethanol</keyword>
</DOC>